Latest ArticlesPolyvinyl alcohol(PVA)-based phase-transition microneedles can be utilized to load drugs through pores formed by swelling, and are highly promising for biomolecular drug delivery. However, due to the drug distribution at the root and center of drug-loaded microneedles prepared by the conventional premixing method, the diffusion distance during drug release is large and penetration through the hydrogel network matrix is difficult, which limit the bioavailability of the drug. Therefore, the diffusion method was used for protein drug-loading and the mass ratio of PVA solution to excipient (sodium carboxymethylcellulose and dextran) solution was optimized to improve the drug loading, drug release rate, and epidermal permeability. The results showed that when the mass ratio of PVA solution to excipient solution was 3∶1 and the solid content was 17.8%, the microneedles had high swelling properties and strong mechanical properties, and could effectively deliver the drug to the dermis. Using insulin aspart as a model drug, compared with the traditional premixing method (the transdermal delivery rate was less than 25%), the transdermal delivery rate of drug-loaded microneedles prepared by the diffusion method could reach 31.0% - 34.6%, and the in vitro release rate was up to 93%. The drug-loaded microneedles prepared by the diffusion method can improve the release rate and bioavailability of hydrophilic macromolecules, providing a new strategy for the development of transdermal drug delivery systems.
Wintergreen oil inclusion complexes with α-, β-, or γ-cyclodextrin(CD) were respectively prepared by the saturated aqueous solution method, then their corresponding creams were also prepared. The in vitro transdermal permeation and release behaviors of aforementioned inclusion complex-based creams were investigated by the modified Franz diffusion cell method. The results showed that among the three inclusion complexes of wintergreen oil, the γ-CD inclusion complexes had the highest inclusion rate and yield, which were (88.53±0.72)% and (98.21±0.80)% respectively. And the cream loaded with the γ-CD inclusion complexes also had the highest in vitro transdermal permeation and release rates among the three creams; its in vitro release data were fitted to zero order kinetic model. Compared with the commercially available compound methyl salicylate cream, three creams loaded with different inclusion complexes had lower in vitro transdermal permeation and release rates, but had no obvious skin irritation. It was concluded that the cream loaded with the γ-CD inclusion complexes had good appearance and stability, no skin irritation, and showed a certain therapeutic effect on chronic eczema model rats.
The monosaccharide HPLC fingerprint method of Epimedium polysaccharides using acid hydrolysis by pre-column derivatization was established. The Epimedium polysaccharides were hydrolyzed into monosaccharides by 2.0 mol/L hydrochloric acid and derivatized by 1-phenyl-3-methyl-5-pyrazolone (PMP). Then, the monosaccharide components were detected by HPLC. The YMC-Pack ODS-A column (4.6 mm×250 mm, 5 μm) was used with a mixture of phosphate buffer and acetonitrile as the mobile phase, in a flow rate of 0.8 mL/min and at a detection wavelength of 254 nm. The common fingerprints of forty batches of Epimedii Folium were established with ten common peaks by Similarity Evaluation System for Chromatographic Fingerprint of TCM (Version 2012). Eight peaks in which were identified as D-mannose, D-glucuronic acid, rhamnose, galacturonic acid, D-glucose, galactose, xylose and arabinose by reference substances. Similarity analysis and orthogonal partial least squares analysis were applied to investigate the differences between Epimedium and seven batches of E. wushanense T.S. Ying. The similarities were less than 0.9, and four monosaccharides showing significant differences were distinguished. The established method is simple and repeatable, which can provide references for the quality evaluation of Epimedium.
A supercritical fluid chromatography (SFC) method was established for the separation and determination of erlotinib hydrochloride(1) and its four related substances. A Torus 2-PIC column (3.0 mm×100 mm, 1.7 μm) was used with the mobile phase containing a mixture of supercritical CO2 and methanol by gradient elution. The injection volume was 1 μL, the column temperature was 50 ℃, and the flow rate was 1.0 mL/min. The results showed that each compound peaked and was completely separated within 7 minutes. And it was linear for four related substances and 1 in the ranges of 0.5 – 40,2 – 60, 0.4 – 40, 0.5 – 40, 5 - 100 μg/mL, respectively. The LODs of 1 and impurities A, B, C, D were 0.2, 0.2, 0.5, 0.1,0.2 μg/mL, respectively, and the LOQs were 0.5, 0.5, 2.0, 0.4, 0.5 μg/mL, respectively. The recoveries (n=3) of four related substances were between 96.0% and 104.2%, with RSDs all less than 3.0%. The established method is rapid, effective, highly sensitive, environmentally friendly, which can be effectively used for quality control of 1 bulk drug and tablets.
The dissolution of cetylpyridinium chloride(1) buccal tablets was determined by flow-through cell method, and the concentration of the dissolution medium, the construction method and amount of glass beads, and the flow rate of the flow-through cell were optimized. Meanwhile, the dissolution curves of the self-made and reference samples were tested using the established method. The results showed that the concentration of the dissolution medium and the amount of glass beads had little effect on the release behavior, while different glass bead construction methods and flow rates of the flow-through cell had a significant effect on the release behavior. This method has certain feasibility and discriminatory ability, which can be used to evaluate the in vitro dissolution behavior of 1 buccal tablets.
An HPLC method was established to determine the related substances in calcium dibutyryladenosine cyclophosphate(1) bulk drug, which were sodium 2′-O-monobutyryladenosine cyclophosphate(3), sodium N6-monobutyryladenosine cyclophosphate(4) and adenosine cyclophosphate(5). The ODS Hypersil column (4.6 mm×200 mm,5 μm) was used, with 0.1 mol/L potassium dihydrogen phosphate solution-methanol (600∶400) as the mobile phase. The detection wavelength was 273 nm, the column temperature was 30 ℃ and the flow rate was 1.0 mL/min. A main component self-compare with correction factor method was established to determine three known impurities, and the correction factors of impurities 3, 4, and 5 to the principal component were determined to be 1.7, 0.9, and 1.4, respectively. The results showed that it was linear for sodium dibutyryladenosine cyclophosphate(2), 3, 4, 5 in the ranges of 0.1 - 20,4 - 20, 1 - 20, 0.1 - 2 μg/mL, respectively. The average recoveries (n=2) of 3, 4 and 5 were 101.0%, 98.5%, and 99.7%, respectively, and the precision RSDs(n=6) were 0.1%, 0.2%, and 0.1%, respectively. The repeatability RSDs (n=6) were 1.5%, 1.6%, and 2.5%, respectively. The detection limits for 3, 4, 5, and 1 were 0.2, 0.1, 0.1, and 0.2 ng, respectively. This method has good specificity, accuracy, and sensitivity, which can provide a reference for quality research of 1.
An HPLC method was established to determine the related substances in N-tert-butoxycarbonyl-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid(1), a key starting material for lifitegrast. A Thermo AcclaimTM Mixed-Mode WAX-1 column (4.6 mm×250 mm, 5 μm) was used, and the analysis was carried out in the gradient elution mode with 30 mmol/L potassium dihydrogen phosphate solution-acetonitrile (95∶5) as mobile phase A, and acetonitrile-tetrahydrofuran (80∶20) as mobile phase B. The flow rate was 0.9 mL/min, the column temperature was 30 ℃, the detection wavelength was 205 nm, and the injection amount was 50 μL. The results showed that the separation between the main component and various impurities was good, and it was linear for the main component and various impurities in the corresponding concentration ranges. The average recoveries (n=9) were 96.4% - 105.6%, with the RSDs less than 5.1%. This method is easy to operate, accurate, and reliable, which is suitable for the determination of related substances in 1.
A cocrystal of hydrochlorothiazide(1) and flucytosine(2) was prepared to improve the solubility of 1 and the hygroscopicity of 2. The 1-2 cocrystal was characterized by single-crystal X-ray diffraction, powder X-ray diffraction, Fourier transform infrared spectroscopy, thermogravimetry, and differential scanning calorimetry. The solubility and hygroscopicity of the 1-2 cocrystal were also examined. Compared with 1, the equilibrium solubility and intrinsic dissolution rate of 1 in the 1-2 cocrystal in hydrochloric acid (pH 1.2), phosphate buffer (pH 6.8), and pure water (pH 7.0) were increased. Meanwhile, the weight of 1-2 cocrystal did not increase under the conditions of 25 ℃ and relative humidity of 95%. These results indicated that the solubility of 1 was increased and the hygroscopicity of 2 was weakened by forming a cocrystal of 1 and 2, which provided a reference for the research on improving the solubility of poorly water-soluble drugs.
In order to explore the impact of sterilizing filtration in the produce process of semi-finished products on the quality attributes of trivalent rotavirus vaccines, and to evaluate the feasibility of implementing sterilizing filtration in this produce process, sterilizing filtration experiments of 22 batches of semi-finished product were conducted in two stages. The test filter membrane had a pore size of 0.22 μm and was made from polyvinylidene fluoride (PVDF). The effect of sterilizing filtration on virus titer, appearance, pH value, osmotic pressure, and clarity of the test products was investigated, and a bacterial interception test on the proposed selected filter membrane material was performed. The results indicated that the PVDF sterilizing filter with a pore size of 0.22 μm for the sterilizing filtration of the semi-finished trivalent rotavirus vaccines did not significantly affect the virus titer, appearance, pH value, and osmotic pressure of the test products (P>0.05), but notably enhanced the clarity of the test products(P<0.05). This research provides valuable data and insights for applying sterile filtration to the formulation process of the semi-finished trivalent rotavirus vaccines.